Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.

作者: Yun Dai , Jorge A Almenara , Roberto R Rosato , Steven Grant

DOI:

关键词: Molecular biologyJurkat cellsBiologyCaspase 3Death domainApoptosisSodium butyrateInhibitor of apoptosisCaspase 8Histone deacetylaseCell biology

摘要: Interactions between histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), also known as Apo2 ligand, were examined in human leukemia cells (e.g., U937, Jurkat, HL-60). Simultaneous exposure of to 100-ng/ml TRAIL with either 1-mM sodium butyrate or 2- micro M suberoylanilide hydroxamic acid resulted a striking increase leukemic cell mitochondrial damage, caspase activation, apoptosis. Lethal effects significantly diminished U937 ectopically expressing dominant-negative caspase-8, Fas-associated death domain, CrmA (receptor pathway), Bcl-2 Bcl-X(L) (mitochondrial pathway). Analysis events exposed TRAIL/HDAC revealed enhanced Bid activation Bax translocation, loss membrane potential, cytoplasmic release cytochrome c, Smac/DIABLO, factor. No changes observed expression FLICE-like inhibitory protein, receptors, reactive oxygen species generation. inhibitor-induced apoptosis triggered caspase-dependent cleavage p21(WAF1/CIP1); moreover, enforced nuclear localization signal deletant form p21(WAF1/CIP1) lethality. Lastly, p27(KIP1), pRb, X-linked inhibitor apoptosis, displayed extensive proteolysis. These findings indicate that coadministration HDAC synergistically induces myeloid provide further evidence simultaneous the extrinsic intrinsic pathways such leads dramatic injury cascade.

参考文章(89)
Guido Kroemer, John C. Reed, Mitochondrial control of cell death Nature Medicine. ,vol. 6, pp. 513- 519 ,(2000) , 10.1038/74994
Jinghai Wen, Nimmanapalli Ramadevi, Diep Nguyen, Charles Perkins, Elizabeth Worthington, Kapil Bhalla, Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells Blood. ,vol. 96, pp. 3900- 3906 ,(2000) , 10.1182/BLOOD.V96.12.3900
Ulrich Mahlknecht, Dieter Hoelzer, Histone acetylation modifiers in the pathogenesis of malignant disease. Molecular Medicine. ,vol. 6, pp. 623- 644 ,(2000) , 10.1007/BF03402044
Dario C. Altieri, Anthony D. Sandler, Takeo Azuhata, David L. Scott, Nathan R. Wall, Jonathan M. Fialkov, Thomas S. Griffith, Richard D. Williams, Induction and Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Apo-2 Ligand-mediated Apoptosis in Renal Cell Carcinoma Cancer Research. ,vol. 62, pp. 3093- 3099 ,(2002)
Victoria M. Richon, Richard A. Rifkind, Paul A. Marks, Ronald Breslow, Inhibitors of histone deacetylase are potentially effective anticancer agents. Clinical Cancer Research. ,vol. 7, pp. 759- 760 ,(2001)
Srikumar P. Chellappan, Gina Fusaro, Heidi M. Sankala, Paul Dent, Roy H. Decker, Zhiliang Wang, Steven Grant, Karen G. Hirsch, Leanne Cartee, The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells. Cancer Research. ,vol. 61, pp. 2583- 2591 ,(2001)
J. M. Adams, The Bcl-2 Protein Family: Arbiters of Cell Survival Science. ,vol. 281, pp. 1322- 1326 ,(1998) , 10.1126/SCIENCE.281.5381.1322
A. A. Ruefli, M. J. Ausserlechner, D. Bernhard, V. R. Sutton, K. M. Tainton, R. Kofler, M. J. Smyth, R. W. Johnstone, The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 10833- 10838 ,(2001) , 10.1073/PNAS.191208598